Chapel Hill-based startup Renovion – which is developing a nebulized therapy called Arina-1 for the treatment of lung transplant patients– has its eyes on submitting a New Drug Application to the U.S. Food and Drug Administration in early 2019, according to chief executive officer Dan Copeland. (Triangle Business Journal)
Recent Campus Connections News:
Ackland Art Museum's largest gift ever – valued at $25 million, includes 7 Rembrandt drawings
Wednesday January 25, 2017
UNC alum Billy Crudup, the leading man who almost was, makes a character-actor leap
Monday January 23, 2017
A day in the life of University archivist: Giving value to ignored voices
Monday January 23, 2017
At North Carolina Children's Hospital, sealed chamber brings wonders of nature to hospitalized kids
Sunday January 22, 2017